Compounds > mesalamine

mesalamine and interleukin-8

mesalamine has been researched along with interleukin-8 in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (5.88)18.2507
2000's9 (52.94)29.6817
2010's5 (29.41)24.3611
2020's2 (11.76)2.80

Authors

AuthorsStudies
Amin, MA; Campbell, PL; Harlow, LA; Koch, AE; Tokuhira, M; Volin, MV; Woods, JM1
Campbell, PL; Connors, MA; Koch, AE; Volin, MV; Woodruff, DC1
B Sartor, R; Böcker, U; Herweck, F; Holt, L; Jobin, C; Nebe, T; Panja, A; Rossol, S; Singer, MV1
de Medina, FS; Gálvez, J; Garrido, M; Merlos, M; Ramis, I; Rodríguez-Cabezas, ME; Zarzuelo, A1
An, MM; Fan, KX; Gao, PH; Jiang, YY; Li, HJ; Liu, BG; Song, SC; Zhang, JD; Zhou, Q1
Oka, M1
Campbell, BJ; Corkill, JE; Hart, CA; Rhodes, JM; Roberts, CL; Smith, SL; Subramanian, S; Tam, B; Virji, M; Winstanley, C1
Arriaza, E; Castillejo, MS; Delgado, M; Gisbert, JP; Gonzalez Lara, V; Guijarro, LG; Marin-Jimenez, I; Mate, J; Olleros, T; Pena, AS; Perez-Calle, JL; Prieto-Merino, D1
Fujita, Y; Godai, T; Kawana, I; Koide, T; Matsuda, R; Morohashi, T; Suzuki, S; Takahashi, D; Tokoro, C; Umemura, S; Yamamoto, T1
Babu, D; Kim, AR; Kim, JA; Kim, YH; Lee, JS; Park, SY; Thapa, D; Yang, HC1
Almeida, LM; Dinis, TC; Nunes, C; Paixão, J; Serra, D1
Berg, A; Cheifetz, AS; Farraye, FA; Ganley-Leal, L; Wasan, SK; Zullow, S1
Chen, DL; Chen, X; Dai, YC; Dai, YT; Tang, ZP; Zhang, YL; Zheng, L1
Gan, N; Gan, R; Li, H; Pu, H; Sun, Q; Tang, P; Yang, H; Zhang, S; Zhao, L1
Chen, J; Chen, Z; Huang, M; Lang, C; Xue, L; Yang, B; Zhang, Y1
Chai, Y; Guo, W; Li, S; Song, Y; Wu, H; Yuan, N; Zeng, M; Zhao, Y1
Chen, Y; Fan, Y; Li, S; Li, W; Lv, Q; Sun, X; Xie, F; Yang, X1

Reviews

2 review(s) available for mesalamine and interleukin-8

ArticleYear
Antioxidant and anti-inflammatory protective effects of yellowtail (
    Food & function, 2022, Sep-22, Volume: 13, Issue:18

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Arginine; Caco-2 Cells; Claudin-4; Colitis; Cyclooxygenase 2; Dextran Sulfate; Humans; Hydrogen Peroxide; Interleukin-1beta; Interleukin-8; Lipopolysaccharides; Mesalamine; Mice; Mice, Inbred C57BL; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Nucleic Acids; Occludin; Peroxidase; Reactive Oxygen Species; Sulfates; Tumor Necrosis Factor-alpha

2022
Efficacy and Safety of Bifidobacterium Quadruple Viable Bacteria Combined with Mesalamine against UC Management: A Systematic Review and Meta-Analysis.
    Oxidative medicine and cellular longevity, 2022, Volume: 2022

    Topics: Bifidobacterium; C-Reactive Protein; Colitis, Ulcerative; Humans; Interleukin-4; Interleukin-8; Mesalamine; Superoxide Dismutase; Tumor Necrosis Factor-alpha

2022

Trials

3 trial(s) available for mesalamine and interleukin-8

ArticleYear
N-acetyl-L-cysteine combined with mesalamine in the treatment of ulcerative colitis: randomized, placebo-controlled pilot study.
    World journal of gastroenterology, 2008, May-14, Volume: 14, Issue:18

    Topics: Acetylcysteine; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Chemokine CCL2; Colitis, Ulcerative; Drug Therapy, Combination; Female; Free Radical Scavengers; Glutathione; Humans; Interleukin-6; Interleukin-8; Male; Mesalamine; Middle Aged; Pilot Projects; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha

2008
Herpes Zoster Vaccine Response in Inflammatory Bowel Disease Patients on Low-dose Immunosuppression.
    Inflammatory bowel diseases, 2016, Volume: 22, Issue:6

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Viral; Cells, Cultured; Female; Herpes Zoster Vaccine; Humans; Immunoglobulin G; Immunosuppressive Agents; Inflammatory Bowel Diseases; Interleukin-8; Leukocytes, Mononuclear; Male; Mesalamine; Middle Aged; Prospective Studies; Tumor Necrosis Factor-alpha

2016
Efficacy of mesalazine in combination with bifid triple viable capsules on ulcerative colitis and the resultant effect on the inflammatory factors.
    Pakistan journal of pharmaceutical sciences, 2018, Volume: 31, Issue:6(Special)

    Topics: Adult; Bifidobacterium; Colitis, Ulcerative; Drug Therapy, Combination; Enterococcus; Female; Humans; Interleukin-10; Interleukin-8; Lactobacillus acidophilus; Male; Mesalamine; Probiotics; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha

2018

Other Studies

12 other study(ies) available for mesalamine and interleukin-8

ArticleYear
Treatment with sulfasalazine or sulfapyridine, but not 5-aminosalicyclic acid, inhibits basic fibroblast growth factor-induced endothelial cell chemotaxis.
    Arthritis and rheumatism, 1999, Volume: 42, Issue:9

    Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Biocompatible Materials; Cell Division; Chemokine CCL2; Chemotaxis; Collagen; Drug Combinations; Endothelium, Vascular; Fibroblast Growth Factor 2; Humans; Intercellular Adhesion Molecule-1; Interleukin-1; Interleukin-8; Laminin; Mesalamine; Proteoglycans; Solubility; Sulfapyridine; Sulfasalazine

1999
The effect of sulfasalazine on rheumatoid arthritic synovial tissue chemokine production.
    Experimental and molecular pathology, 2002, Volume: 73, Issue:2

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cells, Cultured; Chemokine CCL2; Chemokine CXCL1; Chemokines; Chemokines, CXC; Chemotactic Factors; Culture Media, Conditioned; Female; Fibroblasts; Growth Substances; Humans; Intercellular Signaling Peptides and Proteins; Interleukin-1; Interleukin-8; Male; Mesalamine; Middle Aged; Sulfapyridine; Sulfasalazine; Synovial Membrane

2002
Butyrate modulates intestinal epithelial cell-mediated neutrophil migration.
    Clinical and experimental immunology, 2003, Volume: 131, Issue:1

    Topics: Adjuvants, Immunologic; Anti-Inflammatory Agents, Non-Steroidal; Butyrates; Caco-2 Cells; Chemotaxis, Leukocyte; HT29 Cells; Humans; Interleukin-1; Interleukin-8; Intestinal Mucosa; Mesalamine; Receptors, Interleukin-1; RNA, Messenger; Sulfasalazine; Transcription, Genetic

2003
The intestinal anti-inflammatory activity of UR-12746S on reactivated experimental colitis is mediated through downregulation of cytokine production.
    Inflammatory bowel diseases, 2003, Volume: 9, Issue:6

    Topics: Aminosalicylic Acids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aza Compounds; Azo Compounds; Cell Line; Colitis; Colon; Cytokines; Down-Regulation; Female; Inflammation Mediators; Interleukin-1; Interleukin-8; Mesalamine; Neutrophil Infiltration; Peroxidase; Platelet Activating Factor; Rats; Rats, Wistar; Secondary Prevention; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha

2003
Lymphtoxin beta receptor-Ig ameliorates TNBS-induced colitis via blocking LIGHT/HVEM signaling.
    Pharmacological research, 2005, Volume: 52, Issue:3

    Topics: Animals; CD4-Positive T-Lymphocytes; Colitis; Colon; Disease Models, Animal; Gene Expression Regulation; Immunoglobulins; Interleukin-1; Interleukin-8; Lymphotoxin beta Receptor; Lymphotoxin-alpha; Male; Membrane Proteins; Mesalamine; Rats; Rats, Sprague-Dawley; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Member 14; Receptors, Virus; RNA, Messenger; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor Ligand Superfamily Member 14; Tumor Necrosis Factor-alpha

2005
Pyoderma gangrenosum and interleukin 8.
    The British journal of dermatology, 2007, Volume: 157, Issue:6

    Topics: Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Breast Diseases; Colitis, Ulcerative; Female; Humans; Interleukin-8; Mesalamine; Pyoderma Gangrenosum; Treatment Outcome

2007
Characterization of epithelial IL-8 response to inflammatory bowel disease mucosal E. coli and its inhibition by mesalamine.
    Inflammatory bowel diseases, 2008, Volume: 14, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Cells, Cultured; Colonic Neoplasms; Escherichia coli; Flagellin; Humans; Inflammatory Bowel Diseases; Interleukin-8; Intestinal Mucosa; MAP Kinase Signaling System; Mesalamine

2008
Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.
    Inflammatory bowel diseases, 2009, Volume: 15, Issue:3

    Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Colitis, Ulcerative; Colon; Colonoscopy; Cytokines; Dose-Response Relationship, Drug; Drug Resistance; Female; Follow-Up Studies; Gene Expression Regulation; Granulocytes; Humans; Interleukin-6; Interleukin-8; Intestinal Mucosa; Leukapheresis; Male; Mesalamine; Middle Aged; Polymerase Chain Reaction; Prognosis; Remission Induction; Retrospective Studies; RNA, Messenger; Tumor Necrosis Factor-alpha; Young Adult

2009
Inhibitory effects of an aqueous extract of Cornus kousa Burg. leaves on TNF-alpha-induced chemokine expression and monocyte adhesion to human colonic epithelial cells.
    Archives of pharmacal research, 2009, Volume: 32, Issue:1

    Topics: Anti-Inflammatory Agents; Antioxidants; Cell Adhesion; Chemokine CCL2; Chemokines; Colon; Cornus; Dose-Response Relationship, Drug; Epithelial Cells; Flavonoids; HT29 Cells; Humans; I-kappa B Proteins; Interleukin-8; Mesalamine; Monocytes; NF-kappa B; NF-KappaB Inhibitor alpha; Phenols; Plant Extracts; Plant Leaves; Polyphenols; RNA, Messenger; Tumor Necrosis Factor-alpha; U937 Cells

2009
Cyanidin-3-glucoside suppresses cytokine-induced inflammatory response in human intestinal cells: comparison with 5-aminosalicylic acid.
    PloS one, 2013, Volume: 8, Issue:9

    Topics: Anthocyanins; Anti-Inflammatory Agents; Cell Line; Cell Nucleus; Cell Survival; Cyclooxygenase 2; Cytokines; Dinoprostone; Enzyme Activation; Glucosides; HT29 Cells; Humans; Inflammation; Inflammation Mediators; Inflammatory Bowel Diseases; Interleukin-8; Intestinal Mucosa; Mesalamine; Nitric Oxide; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Phosphorylation; STAT1 Transcription Factor; Transcription Factor RelA

2013
Jianpi Qingchang decoction alleviates ulcerative colitis by inhibiting nuclear factor-κB activation.
    World journal of gastroenterology, 2017, Feb-21, Volume: 23, Issue:7

    Topics: Animals; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Drugs, Chinese Herbal; Inflammation; Interleukin-1beta; Interleukin-8; Male; Mesalamine; Mice; Mice, Inbred C57BL; NF-kappa B; Signal Transduction; Tumor Necrosis Factor-alpha

2017
Mesalazine/hydroxypropyl-β-cyclodextrin/chitosan nanoparticles with sustained release and enhanced anti-inflammation activity.
    Carbohydrate polymers, 2018, Oct-15, Volume: 198

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; Anti-Inflammatory Agents, Non-Steroidal; Cell Survival; Chitosan; Delayed-Action Preparations; Dinoprostone; Drug Carriers; Drug Liberation; HT29 Cells; Humans; Interleukin-8; Mesalamine; Nanoparticles; Nitric Oxide; Solubility

2018